Financials LOWL FARM Canadian Securities Exchange

Equities

LOWL

CA5475721075

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange 03:58:47 2024-04-22 pm EDT 5-day change 1st Jan Change
0.11 CAD -8.33% Intraday chart for LOWL FARM 0.00% -52.17%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 248.6 64.32 31.48 11.42 3.145
Enterprise Value (EV) 1 281.6 92.05 82.66 74.12 19.21
P/E ratio -0.54 x -3.13 x -1.16 x -0.47 x -0.06 x
Yield - - - - -
Capitalization / Revenue 6.71 x 1.51 x 0.59 x 0.26 x 0.11 x
EV / Revenue 7.6 x 2.16 x 1.54 x 1.7 x 0.68 x
EV / EBITDA -6.52 x -21.9 x -4.14 x -5.49 x -1.36 x
EV / FCF -11.5 x -7.01 x -3.99 x -18.2 x 224 x
FCF Yield -8.72% -14.3% -25.1% -5.49% 0.45%
Price to Book 1.12 x 1.9 x 0.5 x 0.26 x 0.27 x
Nbr of stocks (in thousands) 29,926 5,650 9,952 11,061 18,126
Reference price 2 8.308 11.38 3.164 1.032 0.1735
Announcement Date 4/30/20 3/9/21 3/31/22 3/30/23 3/28/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 17.2 37.04 42.62 53.72 43.54 28.26
EBITDA 1 -5.448 -43.17 -4.198 -19.95 -13.5 -14.1
EBIT 1 -5.903 -44.06 -4.86 -20.94 -17.12 -17.56
Operating Margin -34.32% -118.93% -11.4% -38.99% -39.32% -62.13%
Earnings before Tax (EBT) 1 -7.186 -50.55 -12.11 -24.46 -24.37 -37.18
Net income 1 -7.283 -50.75 -12.33 -24.68 -24.56 -37.34
Net margin -42.35% -137% -28.93% -45.93% -56.42% -132.11%
EPS 2 -6.767 -15.45 -3.633 -2.719 -2.200 -2.710
Free Cash Flow 1 -21.65 -24.55 -13.13 -20.72 -4.07 0.0856
FCF margin -125.88% -66.26% -30.8% -38.57% -9.35% 0.3%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/21/19 4/30/20 3/9/21 3/31/22 3/30/23 3/28/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales 1 12.47 15.07 12.41 13.18 8.657 9.288
EBITDA 1 -5.187 -3.639 -0.9 -1.099 -3.481 -4.065
EBIT 1 -6.951 -8.18 -2.459 -3.025 -5.226 -6.406
Operating Margin -55.76% -54.27% -19.82% -22.95% -60.37% -68.97%
Earnings before Tax (EBT) 1 -8.625 -9.991 -3.982 - - -11.15
Net income 1 -8.7 -9.991 -4.057 -4.614 -4.779 -11.11
Net margin -69.78% -66.28% -32.69% -35% -55.2% -119.66%
EPS 2 -1.000 -0.9000 -0.4000 -0.4000 -0.4000 -1.000
Dividend per Share - - - - - -
Announcement Date 11/15/21 3/1/22 5/10/22 8/9/22 11/9/22 3/30/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 33 27.7 51.2 62.7 16.1
Net Cash position 1 9.59 - - - - -
Leverage (Debt/EBITDA) - -0.7637 x -6.605 x -2.566 x -4.646 x -1.14 x
Free Cash Flow 1 -21.7 -24.5 -13.1 -20.7 -4.07 0.09
ROE (net income / shareholders' equity) -50.3% -174% -47.4% -48.6% -41.5% -125%
ROA (Net income/ Total Assets) -14.4% -50.9% -3.72% -11.2% -8.35% -14%
Assets 1 50.53 99.68 331.2 221.3 294.2 266.1
Book Value Per Share 2 3.170 7.420 6.000 6.290 3.950 0.6300
Cash Flow per Share 2 0.9600 0.4100 4.470 0.7100 0.0900 0.1300
Capex 1 2.63 9.99 6.85 3.59 4.25 0.14
Capex / Sales 15.28% 26.97% 16.07% 6.69% 9.76% 0.48%
Announcement Date 5/21/19 4/30/20 3/9/21 3/31/22 3/30/23 3/28/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA